This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by EBELING, P. R. Articles by RIGGS, B. L. Search for Related Content PubMed PubMed Citation Articles by EBELING, P. R. Articles by RIGGS, B. L. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CALCIUM COMPOUNDS CALCIUM, ELEMENTAL

The Nocturnal Increase in Growth Hormone Is not the Cause of the Nocturnal Increase in Serum Osteocalcin^*

Endocrine Research Unit, Mayo Clinic and Mayo Foundation Rochester, Minnesota 55905

Address requests for reprints to: Dr. B. Lawrence Riggs, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905.

Osteoblast activity, as measured by the serum osteocalcin (OC) concentration, increases at night in both normal women and women with postmenopausal osteoporosis. Because there is also a physiological increase in GH during deep sleep and the nocturnal increases in serum OC and GH concentrations both become less pronounced with advancing age, we used somatostatin (SMS) infusion to evaluate the effect of suppression of the nocturnal GH increase on the expected increase in serum OC. Serum OC levels were measured during an 8-h iv infusion of SMS and during a similar infusion of isotonic saline (control night) in five young women (mean age ± SE, 21 ± 2 yr). SMS significantly (P <0.05) decreased secretion of endogenous GH. The mean increases in serum OC concentration were similar during SMS infusion and control nights. Furthermore, the nocturnal pattern of increase in serum OC levels during GH or saline infusions did not differ. From these data, we conclude that the nocturnal increases in serum OC and GH levels are not related.

^* This work was supported in part by Research Grants AG-04875 and RR-00585 from the NIH.

Received December 17, 1990.

This article has been cited by other articles:

				J. A. Clowes, H. C. Allen, D. M. Prentis, R. Eastell, and A. Blumsohn Octreotide Abolishes the Acute Decrease in Bone Turnover in Response to Oral Glucose J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4867 - 4873. [Abstract] [Full Text] [PDF]

				H. M. Heshmati, B. L. Riggs, M. F. Burritt, C. A. McAlister, P. C. Wollan, and S. Khosla Effects of the Circadian Variation in Serum Cortisol on Markers of Bone Turnover and Calcium Homeostasis in Normal Postmenopausal Women J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 751 - 756. [Abstract] [Full Text]